Neurol. praxi. 2012;13(6):333-335

Marijuana and epilepsy: myth and facts

MUDr.Ivana Tyrlíková
Univerzitní centrum pro epilepsii, 1. neurologická klinika, FNsP u sv. Anny, Brno

Marijuana contains more than 480 various chemicals. Cannabinoids, which influence neurotransmission and probably modify brain

plasticity, attract the most interest. This effect of individual cannabinoids is still utilized in treatment of vomiting and nausea, especially

with cancer patients. Existing experimental treatments with epilepsy have ambiguous results. Results of many case studies have shown

a reduction of seizure frequency, whereas other studies have shown an increase in it. One study has proved the protective effect of marijuana

in the new onset of epileptic seizures. Nevertheless, this study and other case studies apply to the marijuana herb rather than

individual chemicals. On the other hand, one controlled study has shown a positive effect of a selected cannabinoid called cannabidiol

on seizure frequency. Some positive results point out the necessity of systematic and controlled research of the effect of individual

cannabinoid chemicals in controlled dosages, rather than (or instead of) experimental use of the whole herb which varies in content

and quantity of individual cannabinoids.

Keywords: epilepsy, marijuana, treatment

Published: December 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tyrlíková I. Marijuana and epilepsy: myth and facts. Neurol. praxi. 2012;13(6):333-335.
Download citation

References

  1. Amar BM. Canabinoids in medicine: A review of the therapeutic potential. Journal of Ethnopharmacology, 2006; 105: 1-25. Go to original source... Go to PubMed...
  2. Ashton CH, Pharmacology and effects of cannabis: a brief review. British Journal of Psychiatry, 2001; 178: 101-106. Go to original source... Go to PubMed...
  3. Backer D, Pryce G, Giovannoni G, Thompson AJ, The therapeutic potential of cannabis. The Lancet, 2003; 2: 291-298. Go to original source... Go to PubMed...
  4. Clark PA, The Ethics of Medical Mariujana: goverment restrictions vs. medical necessity. Journal of Public Health Policy, 2000; 21: 1: 40-60. Go to original source...
  5. Consroe PF, Benedito MA, Leite JR, et al. Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice. Eur. J. Pharmacol., 1982; 83: 293-298. Go to original source... Go to PubMed...
  6. Consroe PF, Wood GC, Buchsbaum H, Anticonvulsant Nature of marijuana smoking. JAMA 1975; 234: 306-307. Go to original source... Go to PubMed...
  7. Cunha JM, Carlini EA, Pereira AE, Ramos OL, Pimentel C, Gagliardi R, Sanvito WL, Lander N, Mechoulan R. Chronic administrativ of cannabidiol to healthy volunteers and epileptic patiens. Pharmacology, 1980; 21: 175-185. Go to original source... Go to PubMed...
  8. Donáth V. Alkohol, drogy a niektoré iné psychotropné látky vo vzťahu k epilepsii, Psychiatr. praxi, 2003; 6: 259-262.
  9. Ellison JM, Gelwan E, Ogletree J, Complex partial seizure symptoms affected by marijuana abuse. Clin Psychiatry, 1990; 51: 439-440.
  10. Fišar Z. Kanabinoidy a duševní chroby, Česká a slovenská psychiatrie, 2008; 104: 297-307.
  11. Gordon E, Devinsky O. Alcohol and Marijuana: Effects on Epilepsy and Use by Patients with Epilepsy Epilepsia, 2001; 42(10): 1266-1272.
  12. Grotenhermen F, Russo E. Cannabis and Cannabinoids, Pharmacology, Toxicology and Therapeutic potential. 2002; The Haworth Press, USA. 38-50.
  13. Gowers WR. Epilepsy and other chronic convulsive disorders, London: Churchill, 223.
  14. Jones RT. Cannabis tolerance and dependence. In Cannabis and Health Hazards (eds. K. O. Fehr, H. Kalant) Toronto. 1983; Addiction Research Foundation.
  15. Ng SK, Brust JCM, Hauser A, Susser M. Illicit drug use and the risk of new onset seizures. Am. J. Epidemiol., 1990; 132: 47-57. Go to original source... Go to PubMed...
  16. Os van J, Bak M, Hanssen M, Bijl RV, Graaf de R, Verdoux H. American Journal of Epidemiology, 2002; 158(4): 319-327.
  17. Reynolds JR. Epilepsy: its symptoms, treatement, and relation to other chronic convulsive diseases. London: Churchill, 1861: 321.
  18. Ries R, Fiellin D, Miller S, Saitzr D. Principles of Addiction Medicine, Wolters Kluwer, 2009.
  19. Hall W, Solowij N. Adverse effects of cannabis, The Lancet, 1998; (352) Issue 9140, 1565. Go to original source... Go to PubMed...
  20. Turkanis SA, Karler R., Central excitatory properties of delta-9-tetrahydrocannabinol and its metabolites in ironinduced epileptic rats Neuropharmacology, 1982; 21: 7-13. Go to original source... Go to PubMed...
  21. Váchová PE, Racková S, Janů L. Neuromechanizmy účinku návykových látek. Česká a slovenská psychiatrie, 2009; 105: 6-8, 263-268.
  22. Wada JA, Osawa T, Corcoran ME. Effects of tetrahydrocannabinols on kindled amygdaloid seizures in Senegalese baboons, Papio papio, Epilepsia, 1975; 16: 439-448. Go to original source... Go to PubMed...
  23. Zagnoni PG, Albano C. Psychostimulants and Epilepsy, Epilepsia, 2002; 43(Supl. 2): 28-31. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.